Generic and. innovative drugs. market in Poland Development forecasts for Publications date: Q Languages: Polish, English

Transcription

1 Generic and innovative drugs market in Poland 2012 Development forecasts for Publications date: Q Languages: Polish, English

2 A word from the author The reimbursement act that entered into force in January 2012 will revolutionise the Polish pharmaceutical market and greatly impact the production of both generic and innovative drugs. The key changes are concerned with fixing the reimbursement expense ceiling at 17% of the whole budget of the National Health Fund, introducing risk-sharing instruments, introducing fixed prices and price margins for refunded drugs, and determining limit groups under a common funding limit. Agnieszka Skonieczna, Senior Pharmaceutical market Analyst The report in brief The report is a comprehensive analysis of the pharmaceutical market in Poland following the introduction of the reimbursement act. It presents the details of the key provisions of the act, as well as the possible actions that companies can take in order to minimise its negative impact. The publication also contains development forecasts for , for both the entire market and the market of prescription medicines broken down into innovative and generic segments. In addition to insightful analysis, the report presents the profiles of top generic and innovative producers in Poland, and an assessment of the impact on each company of the reimbursement act and the changes to the refunded drug lists. 2

3 Key topics covered The share of generic and innovative drugs in the pharmaceutical market and the Rx market - in terms of value and volume Development forecasts for generic and innovative medicines in Poland in Prices of innovative and generic drugs in Poland in comparison to other countries Generic substitution procedures The outlays of the National Health Fund for the reimbursement of chemotherapy and on therapy programmes A comparison of the operating principles of therapy programmes and medication programmes The reimbursement decision-making process in Poland Drug payment structure in Poland from the point of view of the patient and the state Medicines generating the highest reimbursement costs for the National Health Fund New active substances added to the lists of drugs refunded in Poland An analysis of the recent changes on the lists of refunded drugs The expected changes concerning drug reimbursement A summary of the key changes introduced by the reimbursement act Fixed reimbursement outlays of the National Health Fund and the payback mechanism Limit groups An assessment of the effects of the reimbursement act on market players Ways to minimise the negative impact of the reimbursement act on producers in Poland Top manufacturers of innovative and generic medicines in Poland An assessment of the impact of the reimbursement act on the top manufacturers of generic and innovative drugs. 3

4 Get all the details on: Which segment is going to grow faster in the coming years: generic or original medicines? Has the share of original drugs in the Polish pharmaceutical market expanded or contracted in the last few years? Are the prices of generic drugs lower in Poland than in other countries? What are the main implications of the reimbursement act for pharmaceutical companies? Which companies had to lower their prices the most after the negotiations with the Minister of Health? How long is the reimbursement decision-making process in Poland? What are the risk-sharing instruments? What medication/substances may become refunded in Poland in the near future? Prices & licences Language / Licence Single 5 Users Corporate Global English/Polish English and Polish Selected PMR clients: 4

5 PMR Market Insight Methodology This report was prepared using PMR Market Insight methodology developed by PMR which assists in the complex preparation of industry reports. About PMR Read more about PMR Market Insight» PMR Publications ( provides reliable market intelligence for business professionals and analyse the business climate in particular in the construction, retail, IT, telecommunications and pharmaceutical sectors. PMR Publications offers both free and paid subscription newsletters, internet news portals, and in-depth reports. PMR Publications is part of PMR ( a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR key areas of operation include consultancy (through PMR Consulting) and market research (through PMR Research). PMR Ltd. Sp. z o.o., ul. Dekerta 24, Krakow, Poland tel. /48/ , fax /48/ , moreinfo@pmrcorporate.com